Home LiteratureArticle Details
PMID: 23050024 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.

PloS one ·Vol. 7 ·No. 9 ·2012-00-00 ·Pages e46391

Salnikov AV, Liu L, Platen M, Gladkich J, Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J, Schemmer P, Büchler MW, Herr I

Abstract

Tumor hypoxia induces epithelial-mesenchymal transition (EMT), which induces invasion and metastasis, and is linked to cancer stem cells (CSCs). Whether EMT generates CSCs de novo, enhances migration of existing CSCs or both is unclear. We examined patient tissue of pancreatic ductal adenocarcinoma (PDA) along with carcinomas of breast, lung, kidney, prostate and ovary. For in vitro studies, five established PDA cell lines classified as less (CSC(low)) and highly aggressive CSC-like cells (CSC(high)) were examined by single and double immunofluorescence microscopy, wound-, transwell-, and time-lapse microscopy. HIF-1α and Slug, as well as HIF-2α and CD133 were co-expressed pointing to a putative co-existence of hypoxia, EMT and CSCs in vivo. CSC(high) cells exhibited high basal expression of the mesenchymal Vimentin protein but low or absent expression of the epithelial marker E-cadherin, with the opposite result in CSC(low) cells. Hypoxia triggered altering of cell morphology from an epithelial to a mesenchymal phenotype, which was more pronounced in CSC(high) cells. Concomitantly, E-cadherin expression was reduced and expression of Vimentin, Slug, Twist2 and Zeb1 enhanced. While hypoxia caused migration in all cell lines, velocity along with the percentage of migrating, polarized and pseudopodia-forming cells was significantly higher in CSC(high) cells. These data indicate that hypoxia-induced EMT occurs in PDA and several other tumor entities. However although hypoxia-induced EMT signaling occurs in all tumor cell populations, only the stem-like cells acquire high migratory potential and thus may be responsible for invasion and metastasis.

MeSH Terms
Cell Line, Tumor Cell Movement/physiology Epithelial-Mesenchymal Transition/physiology Female Gene Expression Regulation, Neoplastic/genetics,physiology Humans Immunohistochemistry Male Neoplastic Stem Cells/metabolism,pathology Pancreatic Neoplasms/metabolism,pathology Tumor Cells, Cultured
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Salnikov Alexei V
Molecular OncoSurgery Group, Department of General Surgery, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
Liu Li
Platen Mitja
Gladkich Jury
Salnikova Olga
Ryschich Eduard
Mattern Jürgen
Moldenhauer Gerhard
Werner Jens
Schemmer Peter
Büchler Markus W
Herr Ingrid
References (45)
45 references, click to expand
  1. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.
    Cancer Cell. 2009 Mar 3;15(3):232-9 PMID: 19249681
  2. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Oncogene. 2011 Sep 15;30(37):3930-42 PMID: 21478913
  3. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.
    Cancer Res. 2009 Jul 15;69(14):5820-8 PMID: 19584296
  4. Tumor growth need not be driven by rare cancer stem cells.
    Science. 2007 Jul 20;317(5836):337 PMID: 17641192
  5. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer.
    Cancer Res. 2011 Apr 15;71(8):3110-20 PMID: 21343390
  6. Cell death pathways in pancreatitis and pancreatic cancer.
    Pancreatology. 2004;4(6):567-86 PMID: 15550766
  7. Dietary polyphenol quercetin targets pancreatic cancer stem cells.
    Int J Oncol. 2010 Sep;37(3):551-61 PMID: 20664924
  8. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.
    Cell Stem Cell. 2007 Sep 13;1(3):313-23 PMID: 18371365
  9. Molecular requirements for epithelial-mesenchymal transition during tumor progression.
    Curr Opin Cell Biol. 2005 Oct;17(5):548-58 PMID: 16098727
  10. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
    Oncogene. 2011 Nov 24;30(47):4707-20 PMID: 21602879
  11. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
    Cancer Res. 1998 Apr 1;58(7):1408-16 PMID: 9537241
  12. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
    Int J Cancer. 2007 Apr 15;120(8):1634-40 PMID: 17236203
  13. The epithelial-mesenchymal transition generates cells with properties of stem cells.
    Cell. 2008 May 16;133(4):704-15 PMID: 18485877
  14. Efficient tumour formation by single human melanoma cells.
    Nature. 2008 Dec 4;456(7222):593-8 PMID: 19052619
  15. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
    Cancer Res. 2010 Mar 1;70(5):2115-25 PMID: 20160041
  16. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    J Clin Oncol. 2001 Aug 15;19(16):3660-8 PMID: 11504747
  17. NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells.
    Cancer Lett. 2010 Sep 28;295(2):214-28 PMID: 20350779
  18. Prospective identification of tumorigenic breast cancer cells.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 PMID: 12629218
  19. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
    J Clin Invest. 2012 May;122(5):1849-68 PMID: 22505459
  20. Cancer stem cells: mirage or reality?
    Nat Med. 2009 Sep;15(9):1010-2 PMID: 19734877
  21. Identification of human brain tumour initiating cells.
    Nature. 2004 Nov 18;432(7015):396-401 PMID: 15549107
  22. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
    Int J Cancer. 2010 Feb 15;126(4):950-8 PMID: 19676044
  23. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
    Cancer Cell. 2009 Mar 3;15(3):220-31 PMID: 19249680
  24. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
    Nat Cell Biol. 2011 Mar;13(3):317-23 PMID: 21336307
  25. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.
    Virchows Arch. 2003 May;442(5):444-52 PMID: 12692724
  26. Epithelial-mesenchymal transitions in development and pathologies.
    Curr Opin Cell Biol. 2003 Dec;15(6):740-6 PMID: 14644200
  27. Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.
    J Cell Physiol. 2007 Nov;213(2):374-83 PMID: 17680632
  28. Hypoxia, HIF-1, and the pathophysiology of common human diseases.
    Adv Exp Med Biol. 2000;475:123-30 PMID: 10849654
  29. Intermittent blood flow in solid tumours--an under-appreciated source of 'drug resistance'.
    Cancer Metastasis Rev. 2001;20(1-2):57-61 PMID: 11831648
  30. The role of hypoxia-induced factors in tumor progression.
    Oncologist. 2004;9 Suppl 5:10-7 PMID: 15591418
  31. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.
    Oncogene. 2010 Aug 26;29(34):4741-51 PMID: 20531305
  32. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications.
    Wien Med Wochenschr. 2002;152(13-14):334-42 PMID: 12168517
  33. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
    Nature. 1994 Feb 17;367(6464):645-8 PMID: 7509044
  34. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer.
    Clin Cancer Res. 2007 Aug 15;13(16):4769-76 PMID: 17699854
  35. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.
    Int J Cancer. 2009 Jun 15;124(12):2771-9 PMID: 19296540
  36. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Oncol Rep. 2012 May;27(5):1599-605 PMID: 22322379
  37. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.
    Oncogene. 2010 Feb 4;29(5):625-34 PMID: 19946328
  38. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.
    PLoS One. 2012;7(2):e30905 PMID: 22363512
  39. Identification of pancreatic cancer stem cells.
    Cancer Res. 2007 Feb 1;67(3):1030-7 PMID: 17283135
  40. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
    Neoplasia. 2008 Jul;10(7):674-9 PMID: 18592007
  41. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.
    Nat Med. 1997 Feb;3(2):177-82 PMID: 9018236
  42. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer.
    Clin Cancer Res. 2008 Sep 15;14(18):5646-8 PMID: 18794070
  43. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.
    Gut. 2009 Jul;58(7):949-63 PMID: 18829980
  44. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.
    J Natl Cancer Inst. 2001 Feb 21;93(4):266-76 PMID: 11181773
  45. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Gastroenterology. 2011 Jul;141(1):279-91, 291.e1-5 PMID: 21640118
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2012-00-00
Epub
2012-00-26
Pages
e46391
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3458836
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com